Skip to main content

Table 2 Baseline characteristics of COPD and asthma patients

From: A short-term educational program improved physicians’ adherence to guidelines for COPD and asthma in Shanghai

Severity Disease courses Sex Age (yr) BMI Smoking history (pack years) FEV1/FVC FEV1 predicted
   M F      
COPD*
GOLD II 12.9 ± 11.2 10 2 69.7 ± 9.0 22.6 ± 4.6 27.5 ± 30.7 0.64 ± 0.1 0.63 ± 0.1
GOLD III 17.5 ± 14.7 21 0 73.6 ± 9.2 22.2 ± 3.4 33.0 ± 18.7 0.50 ± 0.1 0.39 ± 0.0
GOLD IV 13.6 ± 9.0 8 2 72.0 ± 6.5 19.9 ± 3.1 25.0 ± 17.1 0.54 ± 0.1 0.34 ± 0.2
Asthma
GINA I 1.5 ± 1.3 1 4 50 ± 19.4 22.4 ± 2.7 0 ± 0 0.70 ± 0.2 0.74 ± 0.2
GINA II 12.9 ± 15.8 8 12 51.2 ± 11.3 23.4 ± 5.0 5.2 ± 1.3 0.67 ± 0.3 0.83 ± 0.3
GINA III 17.8 ± 13.7 9 13 46.3 ± 17.8 22.7 ± 2.8 22.2 ± 6.7 0.65 ± 0.2 0.68 ± 0.3
GINA IV 11.7 ± 7.1 5 5 55.7 ± 18.2 22.7 ± 2.8 21.2 ± 10.1 0.63 ± 0.2 0.69 ± 0.2
  1. * GOLD I: mild, GOLD II: moderate, GOLD III: severe, GOLD IV: very severe;
  2. † GINA I: Intermittent, GINA II: Mild persistent, GINA III: Moderate persistent,GINA IV: Severe persistent.
  3. M: male; F: female.